AST SpaceMobile Free cash flow increased by 6.4% to -$309.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 107.8%, from -$149.00M to -$309.66M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a 85.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$34.12M | -$24.54M | -$25.27M | -$52.17M | -$69.94M | -$45.17M | -$46.47M | -$53.12M | -$57.84M | -$109.54M | -$47.25M | -$87.69M | -$38.35M | -$63.75M | -$110.47M | -$149.00M | -$353.64M | -$302.89M | -$330.73M | -$309.66M |
| QoQ Change | — | +28.1% | -3.0% | -106.4% | -34.1% | +35.4% | -2.9% | -14.3% | -8.9% | -89.4% | +56.9% | -85.6% | +56.3% | -66.2% | -73.3% | -34.9% | -137.3% | +14.4% | -9.2% | +6.4% |
| YoY Change | — | — | — | — | -105.0% | -84.1% | -83.9% | -1.8% | +17.3% | -142.5% | -1.7% | -65.1% | +33.7% | +41.8% | -133.8% | -69.9% | -822.1% | -375.1% | -199.4% | -107.8% |